CDT Equity Sets 1-for-20 Reverse Stock Split, Effective Nov. 5

CDT Equity Inc. (Nasdaq: CDT) will carry out a 1-for-20 reverse stock split effective Nov. 5, 2026, the pharmaceutical company said in an 8-K filed Wednesday.

Under the split, every 20 shares of common stock will be combined into one share. The company filed the certificate of amendment with the Delaware Secretary of State on Nov. 2. The split takes effect at 5:00 p.m. Eastern Time on Nov. 5.

Trading and ticker

The common stock is expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis on Nov. 6, 2026, at market open. The ticker stays CDT. The post-split CUSIP number will be 20678X809. The par value and other terms of the common stock will not change.

Share count and fractional shares

Outstanding shares will fall from 20,357,283 to approximately 1,017,864. No fractional shares will be issued. Stockholders of record who would otherwise receive a fraction of a share will get a cash payment equal to that fraction multiplied by the split-adjusted closing price on the Nasdaq Capital Market on Nov. 5, 2026.

The company said its stockholders had previously approved future reverse stock splits and given the board authority to set the split ratios and timing, to maintain compliance with Nasdaq Listing Rules. The last close before the filing was $0.07 on Nov. 3, 2026.